The Latest Technologies in Breast Cancer Therapy

Medical technologies are constantly improving. David Waintrit, founder of the National Breast Center, believes that patients are not always aware of the innovations that help doctors fight breast cancer, which can significantly improve treatment outcomes. He believes that patients should understand what methods oncologists can use; patient awareness will allow them not to fear the diagnosis and hope for an optimal treatment result. The chances of completely curing breast cancer are increasing, and this is largely due to innovative devices and techniques.

Mammaprint Genomic Test: Determines Recurrence Risk

This development by Agendia will help doctors prescribe a more accurate treatment regimen, avoiding unnecessary chemotherapy for patients. Currently, diagnostic methods are widespread that cannot reliably show the risk of breast cancer recurrence. Therefore, at early stages of the disease, patients are prescribed chemotherapy. This will become unnecessary when the Mammaprint 70-Gene Assay is widely used. This genomic test analyzes the genetic code of cancer cells and determines the risk of recurrence. Mammaprint is distinguished from other similar tests by its high accuracy; this innovation will help thousands of patients quickly understand the prospects of disease recurrence. The development has received approval from the U.S. Food and Drug Administration (FDA).

BioZorb Device: Minimizes Radiation Exposure

This innovation, developed by Focal Therapeutics, is intended for use during radiation therapy. When performing breast-conserving surgery or partial resection, BioZorb accurately identifies the target for radiation, thereby reducing the radiation burden on the woman's body. The use of this device minimizes the risk of medical errors during surgical planning. Additionally, with BioZorb, surgeons can achieve better breast shape. Reduced risks and complications after surgery, plus a cosmetic effect, – all this becomes possible with the BioZorb device.

Imaging Device: Helps Avoid Complications

This device can be used during microsurgical, plastic, and reconstructive surgeries; it also has potential in the diagnosis and treatment of gastrointestinal diseases. The portable device SPY (SPY Portable Handheld Imager), developed by Novadaq, allows real-time tracking of blood flow and tissue perfusion during surgery. This increases the chances for women to avoid postoperative complications and enhances the effectiveness of breast reconstruction surgeries.